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Abstract
Gangliosides, added exogenously at concentrations of 10–100 mM, inhibit intrinsic protein kinase activities in purified
rat brain myelin. Multivalent neoganglioproteins – gangliosides covalently attached, via their lipid moieties, to bovine
serum albumin – were much more potent, inhibiting myelin protein phosphorylation half-maximally at a concentration of
100 nM. Different ganglioside conjugates varied 10-fold in inhibitory potency; GT1b-conjugates being the most potent and
GM3-conjugates being the least. Conjugates of ganglioside oligosaccharides, lacking the lipid moiety, did not inhibit myelin
protein phosphorylation, whereas conjugates of sphingosine inhibited nearly as potently as GT1b conjugates. Conjugate-
mediated inhibition of myelin protein phosphorylation was due to inhibition of a protein serine kinase activity rather than
 .activation of a phosphatase activity. We conclude that i clustered gangliosides or sphingosine are potent myelin protein
 .kinase inhibitors, and ii sphingolipid metabolism is not required for myelin protein kinase inhibition. In contrast to their
effects on myelin protein phosphorylation, ganglioside conjugates stimulated phosphorylation of a presumptive axon
membrane protein. The data support the conclusion that gangliosides and other sphingolipids, when appropriately clustered,
are potent modulators of central nervous system protein phosphorylation. q 1997 Elsevier Science B.V.
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1. Introduction
Gangliosides are a diverse class of negatively
charged glycosphingolipids having a hydrophobic ce-
Abbreviations: MBP, myelin basic protein; PKC, Ca2qrphos-
pholipid-dependent protein kinase; BSA, bovine serum albumin;
Sph, sphingosine; GlcSph, glucosylsphingosine; LacSph, lacto-
sylsphingosine; LBP, long myelin basic protein; SBP, short
myelin basic protein; Ganglioside nomenclature is according to
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ramide moiety consisting of a fatty acid amide of
.sphingosine and a hydrophilic carbohydrate chain
containing one or more sialic acids. They are ex-
pressed by all vertebrate tissues, but predominate in
w xthe nervous system 2 . Gangliosides are primarily
expressed on the outer leaflet of the plasma mem-
w xbrane 3 , ideally located for involvement in cell-cell
interactions. Increasing evidence indicates that gan-
gliosides act as modulators of cell functions, includ-
w x w x w xing cell growth 4,5 ; apoptosis 6 ; neuritogenesis 7 ;
w xand differentiation of hematopoetic cells 8,9 , kera-
w x w xtinocytes 10 , neuronal cells 11 , and oligodendro-
w x w xcytes 12 . Many of these actions 4–7,10–12 in-
volve ganglioside modulation of protein kinases.
0005-2736r97r$17.00 q 1997 Elsevier Science B.V. All rights reserved.
 .PII S0005-2736 97 00070-9
( )J.A. Mahoney, R.L. SchnaarrBiochimica et Biophysica Acta 1328 1997 30–40 31
Moreover, less complex sphingolipids including sph-
w x w xingosine 13 , sphingosine-1-phosphate 14,15 , and
w xceramide 16,17 are important intracellular modula-
tors of protein kinases.
The myelin membrane is a multilamellar structure
deposited around many axons in the central and
w xperipheral nervous systems 18 . Although a primary
function of myelin is to provide insulation required
for efficient nerve conduction, there are many
myelin-associated enzymes, such as phospholipases
and protein kinases, which appear to be involved in
w xsignal transduction 19 . In particular, myelin basic
 .protein MBP , a major phosphate acceptor, has a
half-life of several months, whereas the half-life of an
w xMBP phosphate group is only minutes 20 . The
function of MBP phosphate turnover is not known.
Exogenously added gangliosides modulate myelin
w xprotein kinase activities. Kim et al. 21 and Golden-
w xring et al. 22 , reported that different gangliosides, of
which GT1b was the most potent, inhibited
2q  .Ca rphospholipid-dependent protein kinase PKC
in purified rat central nervous system myelin. Subse-
w xquently Chan 23–25 reported that gangliosides in-
hibited the calcium-independent phosphorylation of
some proteins, but stimulated phosphorylation of oth-
ers in guinea pig myelin. Recently, ganglioside GM3
was reported to modulate protein kinase activity in
O2A cells, the precursors of the myelin-producing
w xoligodendrocytes 12 .
In most cases, high concentrations of ganglioside
 .30–250 mM have been used to elicit changes in
myelin protein kinases. It is difficult to establish
whether the observed effects were biophysical – due
to the detergent-like properties of amphipathic gan-
gliosides – or due to specific biochemical effects of
the ganglioside structures. Gangliosides also chelate
w xcalcium through their sialic acid residues 26 , and
many of the reported ganglioside-inhibited protein
kinases are calcium-dependent.
We postulated that synthetic multivalent arrays of
gangliosides, covalently linked through their lipid
moiety to a protein carrier see Fig. 1 for schematic
.structures , may be potent modulators of myelin pro-
tein phosphorylation. These conjugates, termed
neoganglioproteins, have proven valuable in studies
w xof ganglioside binding proteins in the brain 27–29 .
Since the gangliosides are covalently linked to a
hydrophilic protein, presumably with the carbo-
Fig. 1. Sphingolipid-BSA conjugates. The structures of six sphin-
golipid-BSA conjugates used in these studies are shown in
increasing order of complexity. The average density of derivatiza-
tion was determined by using Dionex sialic acid andror neutral
w xsugar analysis 32 , except those marked with an asterisk, which
were estimated by a shift of average molecular weight as mea-
w xsured by mass spectrometry 36 . GT1b conjugates having differ-
ent densities of derivatization were used as indicated in the text.
hydrate portion oriented outward, the problems of
detergent-like membrane perturbation are reduced.
The stable chemistry of their covalent conjugation
makes release, uptake, and metabolism unlikely.
Moreover, since the gangliosides are synthetically
clustered in multivalent arrays, more potent effects
w xmay be expected 30 . Low concentrations of neogan-
glioproteins are less likely to cause the membrane
perturbation or calcium chelation effects associated
with high concentrations of unconjugated ganglio-
sides. We report here that neoganglioproteins and
.other sphingolipid conjugates are potent modulators
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of intrinsic myelin and putative axolemmal protein
phosphorylation.
2. Materials and methods
2.1. Materials
w 32 x g- P ATP was from Dupont NEN Boston, MA,
.USA . Protein kinase inhibitors chelerythrine, H-89,
and KN-62 were from Biomol Plymouth Meeting,
.PA, USA . Bio-Rex RG 501-X8 mixed bed resin and
protein molecular weight markers were from BioRad
 .Hercules, CA, USA . Gangliosides were from Ma-
 .treya Pleasant Gap, PA, USA unless otherwise indi-
 .cated. Bovine brain sphingosine Sph was from Miles
 .Laboratories Elkart, IN, USA . Glucosylsphingosine
 .GlcSph, human Gaucher spleen and lactosylsphin-
 .gosine LacSph were the kind gifts of S. Chatterjee,
The Johns Hopkins School of Medicine, and
 .monosaccharide-conjugated BSA neoglycoproteins
were the kind gifts of Y.C. Lee and R.T. Lee, The
Johns Hopkins University. BSA conjugated with
oligosaccharides released from gangliosides were
w xsynthesized by reductive amination, as described 31 .
All other reagents were from standard suppliers.
2.2. Synthesis of sphingolipid-BSA conjugates
Neoganglioproteins and other sphingolipid-BSA
conjugates used in this study are shown schematically
in Fig. 1. Conjugates were synthesized as described
w xpreviously for GT1b-BSA 32 . Briefly, the lysogan-
glioside forms of GT1b, GM1, and GM3 bovine
.spleen were prepared from their parent gangliosides
w xby alkaline methanolysis 33 . The lysogangliosides,
Sph, GlcSph, or LacSph were incubated with a ten-
fold molar excess of the heterobifunctional
 .crosslinker, succinimidyl 4- N-maleimidomethyl -
cyclohexane 1-carboxylate SMCC, Pierce, Rockford,
.IL, USA in anhydrous dimethylformamide. After
1–2 days at 458C, the resulting sulfhydryl-reactive
maleimidyl intermediates were purified from starting
materials by normal phase silica gel column chro-
 .matography using Iatrobeads Iatron Labs, Tokyo .
Additional sulfhydryl groups were introduced to
 .BSA fatty acid and globulin free, Sigma in the form
of N-acetylthioacetate esters. The protein was incu-
bated in 50 mM HEPES buffer pH 8 with a 20-fold
molar excess of N-succinimidyl S-acetylthioacetate
 .SATA, Pierce for 16 h at 48C. The product, SATA-
BSA, was purified by gel filtration on a Sephadex
 .G-25 column. After deblocking see below , SATA-
BSA was assayed for sulfhydryl content colorimetri-
w xcally 34 , and typically contained 12–15 mol of free
sulfhydryl per mol BSA.
Immediately before the coupling reaction, SATA-
BSA was deblocked by incubation with 50 mM
hydroxylamine HCl, 2.5 mM EDTA, 4 mM sodium
phosphate pH 7.5. After 2 h at room temperature,
 .dithiothreitol 2 mM final was added. After 15 min
at room temperature, the deblocked SATA-BSA was
purified by Sephadex G-25 chromatography in 10
mM sodium phosphate buffer pH 7. Protein-contain-
ing fractions were pooled and quantified by ab-
 .sorbance at 280 nm. Purified SATA-BSA 50 nmol
was added to the dried, maleimide-derivatized sphin-
 .golipid 1 mmol . The progress of the subsequent
coupling reaction was assessed by silica gel TLC, and
was typically maximal after 1–2 days at 48C.
Sphingolipid-BSA conjugates were purified on a
TSK-gel DEAE-5PW HPLC column Tosohaas,
. w xMontgomeryville, PA, USA as described 35 . Ex-
cess free sulfhydryl groups were then reduced and
alkylated as follows. Pooled DEAE fractions were
incubated with 0.6 mM dithiothreitol for 1 h at 378C,
followed by 3 mM iodoacetamide for 1 h at 378C,
followed by 15 mM dithiothreitol for 1 h at 378C,
before desalting on a Sephadex G-25 column eluted
with 10 mM sodium phosphate buffer pH 7. The
degree of derivatization of the conjugates, with the
exception of GlcSph-BSA and Sph-BSA, was mea-
sured by acid hydrolysis of an aliquot of the conju-
gate, followed by sugar analysis as previously de-
w xscribed 32 . Sph-BSA and GlcSph-BSA were ana-
lyzed by matrix-assisted laser desorption mass spec-
w xtrometry 36 , kindly performed by Drs Kathleen
Walker and Robert Cotter, The Johns Hopkins School
of Medicine. The molecular weight of these two
conjugates was estimated, and their valency calcu-
lated based on the increase in molecular weight com-
pared to the parent BSA.
GT1b-neoganglioproteins with valencies between
1 and 4 were synthesized by an alternate linkage
 .procedure utilizing bis sulfosuccinimidyl suberate as
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w xcrosslinker 35 . One preparation of sphingosine-BSA
was synthesized by direct coupling with disuccin-
 .imidyl adipate Fig. 4 only, as indicated .
2.3. Myelin membranes
Male Sprague-Dawley rats were sacrificed by de-
capitation, and their brains rapidly removed and rinsed
in ice cold 0.32 M sucrose. Purified myelin mem-
branes were prepared as described by Norton and
w x Poduslo 37 , except that protease inhibitors 0.5 mM
phenylmethylsulfonyl fluoride, 0.5 mgrml leupeptin,
.2 mgrml aprotinin, and 1 mM EDTA were added to
all solutions. Membranes were stored at y208C in
small aliquots. To ensure removal of EDTA from the
membranes prior to use, aliquots were water-washed
twice by centrifugation at 14 000 rpm in a micro-
centrifuge. Rat brain crude homogenate, and crude
 .  .myelin P2A , synaptosomal P2B , and mitochon-
 .drial P2C fractions were prepared as described
w x27,38 , using the same protease inhibitors as above.
2.4. Myelin protein kinase acti˝ity
Protein kinase reactions were prepared in 500 ml
microcentrifuge tubes in a total volume of 20 ml
containing kinase buffer 50 mM Hepes pH 7.4, 10
mM MgCl , 0.03% Triton X-100, 300 mM CaCl ,2 2
w 2q200 mM EGTA final free Ca concentrations100
x.  .mM , purified myelin membranes 3 mg protein , 36
w 32 x mM g- P ATP typically 1–2 Cirmmol, or approx-
.imately 1 mCi per reaction , and potential effectors as
indicated. Some experiments were performed at dif-
ferent divalent cation concentrations, as noted.
Neoganglioproteins were added from concentrated
stocks in 10 mM sodium phosphate pH 7. Unconju-
gated gangliosides were evaporated from stocks stored
 .in chloroform-methanol-water 4 : 8 : 3 and dissolved
by sonication in water. Reactions were initiated by
w 32 x addition of g- P ATP, and incubated for 5 min or
.as indicated at 308C. The reactions were terminated
by addition of 6.7 ml of 4X SDS sample buffer, to
give final concentrations of 2% SDS, 0.5% dithio-
threitol, 10% glycerol, 60 mM Tris HCl pH 6.8, and
0.005% bromophenol blue.
Samples were electrophoresed on 14=16 cm
SDS-PAGE gels with a linear acrylamide gradient
from 12 to 18%, stained with Coomassie Brilliant
Blue R-250, and dried between sheets of porous
cellophane. Incorporation of 32P was detected by
autoradiography on pre-flashed Kodak X-Omat AR
film at y708C with an intensifying screen. Alterna-
tively, 32P was detected using a Fuji BAS-IIIs imag-
ing plate and Fuji BAS1000 phosphorimage system
for quantification of radiolabel incorporation into in-
dividual SDS-PAGE bands.
2.5. Phosphoamino acid analysis
Phosphoamino acids were analyzed using thin layer
w xelectrophoresis 39,40 . Myelin protein kinase reac-
tions were performed as described above, using twice
w32 xthe volume and four times higher P ATP specific
activity. After SDS-PAGE, the gel was soaked in
water containing Bio-Rex 501-X 8 mixed bed resin
for 30 min, dried, and subjected to autoradiography.
Phosphoprotein bands were excised, rehydrated 50
 . .mM NH HCO , 10 min , forced through a wire4 3
mesh mounted in a syringe barrel, and digested with
 .40 mg of trypsin Worthington, Freehold, NJ, USA
at room temperature overnight. The suspension was
filtered through glass fiber filters, lyophilized, resus-
pended in 100 ml of 5.7 N HCl, sealed in a 200 ml
capillary tube, and hydrolyzed at 1108C for 90 min.
The hydrolyzed sample was lyophilized, resuspended
in 5 ml of electrophoresis buffer pyridine-acetic
 .acid-formic acid-water 1 : 18 : 14 : 267 , pH to 2.5
.with pyridine , mixed with phosphoamino acid stan-
dards, spotted on a 20=20 cm cellulose TLC plate
and electrophoresed at 1000 V for 45 min. Phospho-
amino acids were subsequently detected with ninhy-
drin spray reagent and 32P by autoradiography.
2.6. Protein phosphatase assay
Two identical 100 ml myelin protein kinase reac-
tions were performed as described above. After 5 min
at 308C, 50 ml of 12.5 mM unlabeled ATP f200-
. fold excess in kinase buffer was added to stop
.incorporation of radioactive phosphate either with or
 .  .without 3 mM GT1b BSA 1 mM final . At timed8
intervals from 0 to 30 min, 10 ml aliquots were
removed, mixed with 10 ml 2X SDS sample buffer,
resolved by SDS-PAGE, and 32P incorporation into
proteins quantified using a phosphorimager. In paral-
lel control reactions, addition of phosphatase in-
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 .hibitors 17 mM EDTA and 40 mM NaF , resulted in
no decrease in protein-associated radioactivity over
 .30 min data not shown .
3. Results
3.1. Neoganglioproteins modulate myelin protein
kinase acti˝ity
Highly purified myelin membranes were incubated
w 32 xwith g- P -ATP as described in Section 2. No
exogenous substrate was added, therefore, protein
phosphorylation was dependent on both endogenous
protein kinases and endogenous protein substrates.
When parallel reactions were performed in the pres-
 .ence or absence of 500 nM GT1b BSA, marked8
effects on protein phosphorylation were noted Fig.
.2 . The most striking effect was a sharp decrease in
the rate of phosphorylation of a protein doublet with
 .apparent molecular weight of 25 kDa pp25 and a
protein with apparent molecular weight of 20 kDa
 .pp20 . In contrast, the phosphorylation of proteins
with apparent molecular weights of 21 and 17 kDa
were unaffected or enhanced under these experimen-
tal conditions. Based on their comigration with known
myelin proteins, the 21 and 17 kDa phosphoproteins
  .are designated as myelin basic proteins long LBP
 ..and short SBP . The identities of pp25 and pp20 are
not known, although they may be splice variants of
w xthe myelin basic proteins 41 . In some experiments
 .pp25 appeared to be a doublet Fig. 2 , the upper
band of which migrated near myelin proteolipid pro-
tein. However, the lower band of the pp25 doublet
did not comigrate with any major myelin protein, and
there have been no published reports of phosphoryla-
 .Fig. 2. Time course of myelin protein phosphorylation: effect of GT1b BSA. Purified myelin membranes were incubated in kinase8
w 32 x w 2qx .buffer containing g- P ATP at 308C for the indicated times Mg s40 mM . The reactions in the right panel contained 500 nM
 .GT1b BSA. The reactions were stopped by addition of SDS sample buffer and subjected to SDS-PAGE, followed by autoradiography.8
 . Molecular mass markers in kDa are indicated at the left; major phosphoprotein designations are indicated at the right LBP, long myelin
.basic protein; SBP, short myelin basic protein .
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tion of proteolipid protein. Since the doublet bands of
pp25 were not well resolved, they are treated as a
single species for quantification.
To determine the divalent cation dependence of
phosphorylation, kinase reactions were performed
2q 2q with varying amounts of Mg and Ca data not
. 2qshown . Omission of Ca had no significant effect
on the incorporation of radiolabel or inhibition by
 . 2qGT1b BSA. The effects of Mg were complex.8
Radiolabel incorporation into pp25 and pp20 was
2q  .maximal at 20 mM Mg , and GT1b BSA inhib-8
ited their phosphorylation at all Mgq2 concentrations
tested. In contrast, incorporation of radiolabel into
LBP and SBP was maximum at 10 mM Mg2q. At
2q  .this Mg concentration, GT1b BSA inhibited8
phosphorylation of these proteins, whereas at higher
 .concentrations 40 mM, see Fig. 2 phosphorylation
was either unchanged or slightly enhanced. Since we
observed striking inhibition of pp25 and pp20 phos-
phorylation by neoganglioproteins over a broad range
of Mg2q concentrations, subsequent studies focused
on these species, using 10 mM Mg2q.
Many protein-carbohydrate interactions have rela-
tively low single-site affinities, but show markedly
increased affinity when multiple copies of the carbo-
w xhydrate are appropriately clustered 42 . To determine
whether neoganglioprotein inhibition of myelin pro-
tein kinase activity exhibits this ‘cluster effect’,
myelin protein kinase assays were performed in the
presence of unconjugated GT1b and a series of GT1b
 .neoganglioproteins Fig. 3 . The clustered presenta-
tion of ganglioside determinants on the neoganglio-
protein resulted in a 1000-fold increase in inhibitory
  .potency comparing GT1b IC f100 mM and50
 .  ..GT1b BSA IC f100 nM . Kinase inhibitory8 50
potency correlated with derivatization density:
 .  .  .GT1b BSA4 GT1b BSAs GT1b BSA)8 4 2
 .GT1b BSA. These data also indicate that the link-1
age chemistry of the ganglioside to BSA was not
 .responsible for the inhibition, in that GT1b BSA4
was a highly potent inhibitor, although the GT1b was
linked via an alternate synthetic scheme which did
w xnot utilize thioesters 35 . The increased inhibitory
 .potency of GT1b BSA over unconjugated GT1b1
 .f10-fold even though both are ‘monovalent’, may
be due to the presence of higher order derivatives in
 .the GT1b BSA preparation, which has an a˝erage1
of one GT1b per BSA molecule. Intermediate va-
Fig. 3. Effect of multivalency on the inhibitory potency of
GT1b-neoganglioproteins. Myelin membranes were incubated
w 32 xwith g- P ATP under standard assay conditions in the presence
of various concentrations of unconjugated gangliosides GT1b and
GM1, or with the following GT1b-neoganglioproteins: GT1b-8,
 .  .GT1b BSA; bGT1b-4, biotinylated GT1b BSA; GT1b-2,8 4
 .  .GT1b BSA; GT1b-1, GT1b BSA. The reactions were stopped,2 1
and 32P incorporation into pp25 was analyzed by SDS-PAGE and
phosphorimage analysis. Data are the means of duplicate determi-
nations.
lency conjugates were not tested at concentrations
greater than 10 mM due to limited availability.
3.2. Structural specificity of neoganglioprotein
inhibition
The specificity of neoganglioprotein inhibition of
myelin protein phosphorylation was investigated by
comparing the effects of structurally related BSA
conjugates. Neither BSA alone, nor BSA derivatized
 .with monosaccharides Gal, GalNAc, Glc, or Man
had any inhibitory activity when tested at 2.5 mM, a
 .value 25-fold higher than the IC for GT1b BSA50 8
 w x.data not shown, 43 . Notably, when the oligo-
saccharide portion was released from of GT1b, and
covalently attached to BSA, the resulting conjugate
 . .oligoGT1b BSA did not inhibit phosphorylation12
 .Fig. 4 . In contrast, a conjugate having sphingosine
 .covalently linked to BSA via disuccinimidyl adipate
inhibited myelin protein phosphorylation. These data
indicated that the clustered sphingosine moiety was
necessary and perhaps sufficient for ganglioside mod-
ulation of myelin protein phosphorylation.
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Fig. 4. Structural specificity of neoganglioprotein inhibition of
myelin protein kinase activity. Myelin protein kinase reactions
were performed under standard conditions in the presence of 500
nM of the indicated BSA conjugates. Reactions were stopped,
and subjected to SDS-PAGE and autoradiography. Assays were
performed in duplicate, and electrophoresed in adjacent lanes on
 .the gel. Molecular mass markers in kDa are shown at the left.
Ganglioside designations preceded by an ‘o’ indicate conjugates
in which the oligosaccharide released from the respective gan-
w xglioside was linked to BSA by reductive amination 31 . SGNL
designates the oligosaccharide 3-sulfo-glucuronylneolactotetrose
w xlinked to BSA by reductive amination 52 . The valency of the
 . .disuccinimidyl adipate-linked sphingosine-BSA Sphing BSAn
used in this particular experiment unlike subsequent experi-
.ments was not determined.
Based on these data, a series of multivalent lig-
ands, containing sphingolipids of varying complexity
 .were constructed Fig. 1 . All lipids were linked
using the same chemistry, and the conjugates con-
tained 8 to 17 lipid molecules per BSA. Conjugates
were tested for their ability to inhibit radiolabeled
 .phosphate incorporation into myelin proteins Fig. 5 .
The most striking result from these studies was that
all of the conjugates were inhibitory, including
 .Sph BSA, which contains no carbohydrate. How-10
ever, conjugates containing different oligosaccharide
structures exhibited a range of potencies:
 .  .GT1b BSA and GT1b BSA were 6–10-fold more8 13
potent inhibitors of phosphorylation than
 .GM3 BSA.17
3.3. Characterization of the neoganglioprotein-
modulated myelin protein kinase acti˝ity
Decreased phosphorylation of a protein may result
from inhibition of protein kinases, stimulation of
protein phosphatases, or both. The effect of
 .GT1b BSA on protein phosphatase activity in8
myelin membranes was measured as described in
Section 2. Phosphatase activity was assayed as the
time-dependent loss of radioactivity from prelabeled
phosphoproteins, performed either in the presence or
absence of the neoganglioprotein. Addition of
 .GT1b BSA did not stimulate myelin protein phos-8
 .phatase activity data not shown , indicating that the
decrease in protein phosphorylation caused by
neoganglioproteins resulted from a decrease in kinase
activity.
Phosphoamino acid analysis of the major labeled
phosphoproteins in the myelin membranes showed
Fig. 5. Inhibition of myelin protein kinase activity by sphin-
golipid-BSA conjugates. Protein kinase reactions were performed
under standard conditions in the presence of the indicated con-
centrations of various sphingolipid-BSA conjugates. The valency
of each conjugate is listed after the dash, i.e. GT1b-8 is
 . 32GT1b BSA. P incorporation into pp25 was analyzed by8
SDS-PAGE and phosphorimage analysis. Data are the means of
two experiments, each performed in duplicate.
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that phosphorylation occurred exclusively on serine
 .residues under the conditions used data not shown .
However, the serine protein kinase inhibitors chelery-
thrine, H-89, and KN-62 did not block phosphoryla-
 .tion when used at appropriate concentrations , indi-
cating that the neoganglioprotein-modulated activity
was not among the major classes of serine protein
kinases PKC, cAMP- or cGMP-stimulated protein
kinases, or Caq2rcalmodulin-stimulated protein ki-
.nase respectively . Moreover, kinase activity was not
stimulated by dibutyryl cAMP, dibutyryl cGMP, or
 .calciumrcalmodulin data not shown .
3.4. Brain membrane distribution of
ganglioside-modulated protein kinases
To determine whether the neoganglioprotein-mod-
ulated protein kinase was found in other brain mem-
branes, crude rat brain homogenate was fractionated
by sucrose density centrifugation. The resulting frac-
tions, denoted P2A, P2B, and P2C, represent crude
myelin membranes, synaptosomes, and mitochondria,
respectively. These three membrane fractions, along
with crude brain homogenate and the highly purified
myelin membranes used in all other experiments
were assayed for kinase activity, in the presence or
 .absence of 500 nM GT1b BSA. The gel autoradio-8
gram, shown in Fig. 6, was overexposed to better
 .visualize minor bands. Using either crude P2A or
purified myelin membranes, the same four major
 .species were radiolabeled, and GT1b BSA inhib-8
ited phosphorylation of pp25 and pp20. Phosphory-
lated myelin basic proteins were also visible in P2B
and P2C, presumably due to a small amount of
contaminating myelin in those fractions. There were
many higher molecular weight bands labeled in the
Fig. 6. Brain membrane specificity of neoganglioprotein-modulated protein kinase activity. The indicated brain membrane fractions were
 .assayed for myelin protein kinase activity, as described in Section 2, in the presence or absence of 500 nM GT1b BSA as indicated.8
Homog., crude brain homogenate; P2A, crude myelin fraction; P2B, synaptosome fraction; P2C, mitochondrial fraction; Myelin, highly
purified myelin membranes. Reactions were performed in duplicate and electrophoresed in adjacent lanes except single lanes for purified
.  .myelin . Molecular mass markers in kDa are shown at the left.
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crude homogenate and non-myelin fractions, but none
was markedly or reproducibly modulated by neogan-
glioprotein.
The P2A reaction produced an unexpected result:
 .phosphorylation of a small protein f12 kDa , which
was not apparent in reactions using purified myelin,
was stimulated by neoganglioprotein phosphoryla-
tion of 40 and 66 kDa proteins was less dramatically
.stimulated . Half-maximal stimulation occurred at a
 . GT1b BSA concentration of 300 nM data not8
.  .shown . The 12 kDa phosphoprotein pp12 was not
detected in any reaction using the more highly puri-
w xfied Norton-Poduslo 37 myelin, with or without
neoganglioprotein present. The Norton-Poduslo pro-
cedure includes hypo-osmotic shock to disrupt myelin
whorls into small fragments, releasing the axonal
 .plasma membrane axolemma which is then re-
moved by discontinuous sucrose gradient centrifuga-
tion. Since osmotic shock is not part of the P2A
preparation, it is reasonable to speculate that pp12 is
localized to the axolemma.
The structural specificity of stimulation of pp12
phosphorylation with sphingolipid conjugates was
similar to that for inhibition of phosphorylation of
 .myelin-specific proteins: GT1b BSA and8
 .Sph BSA were the most effective, whereas10
 . GlcSph BSA was the least effective data not10
.shown . However, unconjugated GT1b, at high con-
 .centrations 100 mM modestly inhibited pp12 phos-
 .  .  .phorylation 45% , whereas GT1b BSA 300 nM8
stimulated phosphorylation. These data indicate that
exogenously added unconjugated gangliosides, at high
concentrations, may have biophysical or biochemical
effects distinct from those of the more potent gan-
glioside conjugates.
4. Discussion
Although control of myelin protein kinase activity
w xby gangliosides has been reported previously 21–23 ,
the covalent ganglioside conjugates used in the cur-
rent study demonstrate the following additional major
 .points. i Clustered gangliosides are potent kinase
modulators. Their ability to inhibit myelin protein
kinase activity at nanomolar concentrations is indica-
tive of a direct biochemical mechanism, rather than
an alteration in ‘bulk’ membrane properties or indi-
 .rect chelation of divalent cations. ii Metabolism of
gangliosides is not required for kinase modulation.
Synthetic ganglioside conjugates, in which the gan-
gliosides are linked to BSA via stable thioether and
amide linkages, are not likely to be readily metabo-
lized. Yet they are 1000-fold more potent than uncon-
jugated gangliosides in modulating myelin protein
kinase activity, indicating that metabolism to active
species such as ceramide and sphingosine is an un-
likely mechanism for ganglioside-mediated kinase
modulation. The observation that GT1b and sphingo-
sine derivatives synthesized using alternative
chemistries had similar effects, combined with the
lack of effect by BSA alone, indicates that the carrier
or coupling chemistry is not responsible for kinase
modulation. Therefore, data presented here support
the hypothesis that gangliosides and other sphin-
golipids play important regulatory roles in the enzy-
matic activity of central nervous system myelin.
It is unknown whether the ganglioside conjugates
 .described here act primarily on the kinase s present
in myelin or on kinase substrates. Inhibition of multi-
ple distinct myelin polypeptide substrates suggests
that the ganglioside conjugates may act on the en-
zyme, either directly or through a signaling pathway.
Ganglioside GM3 inhibits epidermal growth factor
receptor autophosphorylation through direct interac-
w xtion of the ganglioside with the enzyme. 5,44 . In
contrast, GM1 appears to stimulate phosphorylation
of tyrosine hydroxylase in PC12 cells indirectly, by
2q w xmodulating voltage-sensitive Ca channels 45 .
These studies indicate that gangliosides utilize multi-
ple mechanisms to modulate protein kinases.
The identity of the ganglioside-modulated protein
kinase responsible for myelin protein phosphorylation
in the current study was not determined, although it
does not appear to be one of the major known protein
kinases. For instance, although sphingolipids modu-
w x w xlate PKC 46 , and PKC is abundant in myelin 47 ,
the major form of calcium-dependent PKC was not
the ganglioside-modulated protein kinase responsible
 .for phosphorylation in the current study since: i
Ca2q was not required for activity, nor was activity
significantly stimulated by the addition of Ca2q or
2q  .  .Ca rphosphatidylserine not shown , and ii the
PKC-specific inhibitor, chelerythrine, did not block
the activity when used at concentrations which typi-
cally block PKC. In previous reports on ganglioside
( )J.A. Mahoney, R.L. SchnaarrBiochimica et Biophysica Acta 1328 1997 30–40 39
modulation of myelin protein kinase activities the
properties of the kinases under study varied. In the
w x 2qwork of Chan 23 , as in the present study, Ca was
not required for kinase activity, whereas Kim et al.
w x21 reported that the ganglioside-inhibited myelin
protein kinase activity in myelin was PKC, based on
2q  .its Ca dependence under their conditions and the
w xreported abundance of PKC in myelin 47 .
Myelin protein kinase activity was potently inhib-
ited by all of the sphingolipid-BSA conjugates tested,
 .the best inhibitor being GT1b BSA. This result, and8
 .the weak inhibition by oligoGT1b BSA, suggest12
that the sphingosine moiety, alone or as part of a
ganglioside structure, is necessary and sufficient for
inhibition of the myelin protein kinase activity de-
tected under our conditions. However, the 10-fold
range of potencies observed for conjugates with dif-
ferent oligosaccharide structures indicates that the
carbohydrate moieties contribute to the specificity of
the interaction. The data support the interpretation
that a myelin protein kinase interacts with the sphin-
gosine moiety in each conjugate, but that the oligo-
saccharide structure can either enhance or diminish
the interaction. Although ‘sphingosines’ exist in many
w xmolecular forms 48 , only two are relevant to the
current study, since )95% of the long chain bases
on the gangliosides used are either sphingosine
 .  .C18 : 1 or C-20 sphingosine C20 : 1 . The spleen
 .glycosphingolipids GlcCer, LacCer, GM3 carry ex-
w xclusively sphingosine 49 , whereas the bovine brain
gangliosides and semi-synthetic bovine brain sphin-
.gosine carry about equal amounts of the C18 : 1 and
C20 : 1 forms based on mass spectrometry and gas-
.liquid chromatography, data not shown . Whether the
two forms vary in their ability to modulate myelin
protein phosphorylation was not determined.
The enhanced potency of ganglioside conjugates
 .compared to their unconjugated counterparts Fig. 3
may be due to specific spatial clustering. Spatial
clustering of unconjugated gangliosides also occurs,
via micelle formation. However, the critical micelle
 y8 w x.concentration e.g. f10 M for GM1 50 is far
below the effective concentration for inhibition of
 y5 .myelin protein phosphorylation )10 M, Fig. 3 .
It is possible that synthetic clustering of the sphin-
golipids on BSA generates intermolecular distances
which are either particularly well suited to binding to
target sites on the myelin membrane, or which im-
pose artificial stress on target structures after binding,
thereby altering their activities.
 .Fractionation of brain membranes Fig. 6 indi-
cated that the ganglioside-inhibited kinase activity
was primarily or exclusively found on myelin. Under
the assay conditions employed, the four myelin phos-
phoproteins were the major phosphorylated species,
even in crude brain homogenates. Furthermore,
myelin phosphoproteins were the only species which
were notably inhibited by ganglioside conjugates.
Therefore, it is reasonable to speculate that ganglio-
side regulation of protein phosphorylation is involved
in myelin-specific membrane functions.
Fractionation of brain membranes also led to the
 .discovery of a protein pp12 whose phosphorylation
was markedly stimulated by ganglioside conjugates.
Based on its appearance in partially purified myelin
but in no other membrane fraction including purified
.myelin , this protein may be localized to axolemmal
membranes, which are the neuronal target of myelina-
tion. Axolemma and myelin have different ganglio-
w xside expression 51 . In the rat, axolemma ganglio-
 .sides are mostly polysialylated GT1b, GD1b ,
whereas myelin gangliosides are mostly monosialy-
 .lated GM1 . Whether the differential distribution has
a functional impact on protein phosphorylation in
these membranes has not been determined.
Further elucidation of the mechanisms of ganglio-
side-modulated protein kinase activities await molec-
 .ular identification on the endogenous enzyme s and
substrates involved. The high potency of the ganglio-
side and other sphingolipid conjugates synthesized
for the current study make them powerful tools for
further elucidation of ganglioside-modulated protein
kinase activities.
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